Gastric infection with Helicobacter pylori.
Conditions
Interventions
Intervention 1: Control group: Taking placebo capsules that are completely identical to supplements in weight, size, shape and taste for 14 days in combination with the standard four-dose regimen for
Sponsors
Birjand University of Medical Sciences
ZIST TAKHMIR Pharmaceutical company
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Symptoms of H. pylori-positive as Confirmed by Clinical, Endoscopic, and Pathological Reports.
Exclusion criteria
Exclusion criteria: Pregnancy and lactation Patients with Liver, CardioPulmonary, Renal, Neoplastic Diseases People taking Proton Pump Inhibitors, Bismuth Salts, or Probiotics for the past 4 weeks and any Immuno Suppressive Drugs Surgery such as Gastrectomy or Gastric Bypass The existence of Autoimmune Diseases IBD (Inflammatory Bowel Disease) Organ Transplant Weight loss over 3kg over the past three months Previous History of Helicobacter Pylori Eradication Oral Antibiotic use in less than 3 months Alcohol abuse Participate in Other Clinical Trials Concurrently
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean recovery time in study groups. Timepoint: 2 and 6 weeks after the end of treatment. Method of measurement: Stool Antigen Test.;Frequency distribution of treatment side effects in study groups. Timepoint: During treatment weekly. Method of measurement: Using the questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNushin Naghibzadeh
Birjand University of Medical Sciences
Outcome results
None listed